Christopher Pyke

2.9k total citations · 1 hit paper
69 papers, 2.2k citations indexed

About

Christopher Pyke is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Christopher Pyke has authored 69 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 20 papers in Cancer Research and 10 papers in Surgery. Recurrent topics in Christopher Pyke's work include Global Cancer Incidence and Screening (26 papers), Breast Cancer Treatment Studies (20 papers) and Cancer Risks and Factors (14 papers). Christopher Pyke is often cited by papers focused on Global Cancer Incidence and Screening (26 papers), Breast Cancer Treatment Studies (20 papers) and Cancer Risks and Factors (14 papers). Christopher Pyke collaborates with scholars based in Australia, United States and New Zealand. Christopher Pyke's co-authors include Peter D. Baade, Danny R. Youlden, Nathan Dunn, Susanna Cramb, Jennifer Muller, J. Alejandro López, Jon A. van Heerden, Sandra C. Hayes, John Bashford and Diana Battistutta and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Christopher Pyke

66 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality

2012 542 citations Danny R. Youlden, Christopher Pyke et al. profile →

Peers

Countries citing papers authored by Christopher Pyke

Since Specialization

Citations

This map shows the geographic impact of Christopher Pyke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Pyke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Pyke more than expected).

Fields of papers citing papers by Christopher Pyke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Pyke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Pyke. The network helps show where Christopher Pyke may publish in the future.

Co-authorship network of co-authors of Christopher Pyke

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Pyke. A scholar is included among the top collaborators of Christopher Pyke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Pyke. Christopher Pyke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Improving Breast Cancer Outcomes for Indigenous Women in Australia 2024 ·Cancers ·(unknown), (unknown), (unknown), Janaki Amin, John Skinner, Christopher Pyke, Kylie Gwynne	0
2	Treatment intervals and survival for women diagnosed with early breast cancer in Queensland: the Breast Cancer Outcomes Study, a population‐based cohort study 2023 ·The Medical Journal of Australia ·Kou Kou, Joanne F. Aitken, Christopher Pyke, Suzanne K. Chambers, Jeff Dunn, Peter D. Baade	2
3	Does breast cancer policy meet the needs of Aboriginal and Torres Strait Islander women in Australia? a review 2023 ·International Journal for Equity in Health ·(unknown), (unknown), (unknown), Kylie Snook, (unknown), Boe Rambaldini, Janaki Amin, Christopher Pyke, Megan Varlow, (unknown), John Skinner, Ross D. O’Shea, (unknown), Kylie Gwynne	4
4	A Randomised, Comparative, Effectiveness Trial Evaluating Low- versus High-Level Supervision of an Exercise Intervention for Women with Breast Cancer: The SAFE Trial 2022 ·Cancers ·Rosalind R. Spence, Carolina X. Sandler, Ben Singh, (unknown), Christopher Pyke, Elizabeth Eakin, Dimitrios Vagenas, Sandra C. Hayes	9
5	A cost-consequences analysis of the SAFE trial: a comparative, effectiveness trial evaluating high- versus low-supervision of an exercise intervention for women with breast cancer 2022 ·Breast Cancer ·(unknown), Louisa G. Gordon, Carolina X. Sandler, Rosalind R. Spence, Dimitrios Vagenas, Christopher Pyke, Sandra C. Hayes	1
6	A prognostic survival model for women diagnosed with invasive breast cancer in Queensland, Australia 2022 ·Breast Cancer Research and Treatment ·Peter D. Baade, Helen Fowler, Kou Kou, Jeff Dunn, Suzanne K. Chambers, Christopher Pyke, Joanne F. Aitken	5
7	What Is the Evidence Globally for Culturally Safe Strategies to Improve Breast Cancer Outcomes for Indigenous Women in High Income Countries? A Systematic Review 2021 ·International Journal of Environmental Research and Public Health ·(unknown), (unknown), Janaki Amin, Christopher Pyke, (unknown), John Skinner, (unknown), Kylie Gwynne	10
8	Transverse relaxation‐based assessment of mammographic density and breast tissue composition by single‐sided portable NMR 2019 ·Magnetic Resonance in Medicine ·(unknown), (unknown), Honor J. Hugo, Christopher Pyke, (unknown), Thomas Lloyd, Erik W. Thompson, Konstantin I. Momot	15
9	Breast Cancer Incidence and Survival Among Young Females in Queensland, Australia 2019 ·Journal of Adolescent and Young Adult Oncology ·Danny R. Youlden, Peter D. Baade, Rick Walker, Christopher Pyke, David Roder, Joanne F. Aitken	9
10	T₁‐based sensing of mammographic density using single‐sided portable NMR 2018 ·Magnetic Resonance in Medicine ·(unknown), (unknown), Honor J. Hugo, Christopher Pyke, (unknown), Thomas Lloyd, Erik W. Thompson, Konstantin I. Momot	16
11	Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen 2017 ·Journal of Clinical Pathology ·Cameron Snell, (unknown), (unknown), (unknown), (unknown), (unknown), Kristen Gibbons, Christopher Pyke, Catherine Shannon, Natasha Woodward, Jane E. Armes	8
12	The Impact of Rurality and Disadvantage on the Diagnostic Interval for Breast Cancer in a Large Population-Based Study of 3202 Women in Queensland, Australia 2016 ·International Journal of Environmental Research and Public Health ·Philippa Youl, Joanne F. Aitken, Gavin Turrell, Suzanne K. Chambers, Jeff Dunn, Christopher Pyke, Peter D. Baade	25
13	Analysing risk factors for poorer breast cancer outcomes in residents of lower socioeconomic areas of Australia 2014 ·Australian Health Review ·David Roder, Helen Zorbas, James Kollias, Christopher Pyke, David J. Walters, Ian Campbell, (unknown), Fleur Webster	14
14	Factors predictive of immediate breast reconstruction following mastectomy for invasive breast cancer in Australia 2013 ·The Breast ·David Roder, Helen Zorbas, James Kollias, Christopher Pyke, David J. Walters, Ian Campbell, (unknown), Fleur Webster	32
15	Adherence to Recommended Treatments for Early Invasive Breast Cancer: Decisions of Women Attending Surgeons in the Breast Cancer Audit of Australia and New Zealand 2012 ·Asian Pacific Journal of Cancer Prevention ·David Roder, (unknown), (unknown), Fleur Webster, James Kollias, Christopher Pyke, Ian Campbell	7
16	A multilevel investigation of inequalities in clinical and psychosocial outcomes for women after breast cancer 2011 ·SHILAP Revista de lepidopterología ·(unknown), Peter D. Baade, (unknown), Suzanne K. Chambers, Gavin Turrell, Christopher Pyke, Jeff Dunn	18
17	Prevalence and prognostic significance of secondary lymphedema following breast cancer 2011 ·UWA Profiles and Research Repository (University of Western Australia) ·Sandra C. Hayes, Tracey DiSipio, Sheree Rye, J. Alejandro López, Christobel Saunders, Christopher Pyke, John Bashford, Diana Battistutta, Beth Newman	1
18	Population of HLA-DR+ Immature Cells Accumulate in the Blood Dendritic Cell Compartment of Patients with Different Types of Cancer 2005 ·Queensland's institutional digital repository (The University of Queensland) ·Alberto Pinzón‐Charry, (unknown), R. Laherty, Tammy Maxwell, Dorothy G. Walker, Robert A. Gardiner, Louise O’Connor, Christopher Pyke, Christopher Schmidt, C. M. Furnival, J. Alejandro López	0
19	How can we disseminate psycho-oncology interventions to oncology and community settings? Results from a trial of a self-directed coping training program for women with cancer, and their closest support persons 2003 ·Australian Journal of Psychology ·Jennifer L. Scott, W. Kim Halford, Michael A. McGuckin, B. Ward, (unknown), Christopher Pyke	4
20	IS PARATHYROID HORMONE‐RELATED PROTEIN A SENSITIVE SERUM MARKER IN ADVANCED BREAST CANCER? 1997 ·Australian and New Zealand Journal of Surgery ·Christopher Pyke, (unknown), David M. Purdie, (unknown), David Cowley	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact